A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator

Guy Reed, Aiilyan K. Houng, Lin Liu, Behnaz Parhami-Seren, Lee H. Matsueda, Shunguang Wang, Lizbeth Hedstrom

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Plasminogen (Pg) activators such as streptokinase (SK) save lives by generating plasmin to dissolve blood clots. Some believe that the unique ability of SK to activate Pg in the absence of fibrin limits its therapeutic utility. We have found that SK contains an unusual NH2-terminal "catalytic switch" that allows Pg activation through both fibrin-independent and fibrin-dependent mechanisms. Unlike SK, a mutant (rSKΔ59) fusion protein lacking the 59 NH2-terminal residues was no longer capable of fibrin-independent Pg activation (kcat/Km decreased by >600-fold). This activity was restored by coincubation with equimolar amounts of the NH2-terminal peptide rSK1-59. Deletion of the NH2 terminus made rSKΔ59 a Pg activator that requires fibrin, but not fibrinogen, for efficient catalytic function. The fibrin-dependence of the rSKΔ59 activator complex apparently resulted from selective catalytic processing of fibrin-bound Pg substrates in preference to other Pg forms. Consistent with these observations, the presence (rSK) or absence (rSKΔ59) of the SK NH2-terminal peptide markedly altered fibrinolysis of human clots suspended in plasma. Like native SK, rSK produced incomplete clot lysis and complete destruction of plasma fibrinogen; in contrast, rSKΔ59 produced total clot lysis and minimal fibrinogen degradation. These studies indicate that structural elements in the NH2 terminus are responsible for SK's unique mechanism of fibrin-independent Pg activation. Because deletion of the NH2 terminus alters SK's mechanism of action and targets Pg activation to fibrin, there is the potential to improve SK's therapeutic efficacy.

Original languageEnglish (US)
Pages (from-to)8879-8883
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number16
DOIs
StatePublished - Aug 3 1999

Fingerprint

Streptokinase
Plasminogen Activators
Fibrin
Plasminogen
Fibrinogen
Peptides
Fibrinolysin
Fibrinolysis
Thrombosis

All Science Journal Classification (ASJC) codes

  • General

Cite this

A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator. / Reed, Guy; Houng, Aiilyan K.; Liu, Lin; Parhami-Seren, Behnaz; Matsueda, Lee H.; Wang, Shunguang; Hedstrom, Lizbeth.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 16, 03.08.1999, p. 8879-8883.

Research output: Contribution to journalArticle

Reed, Guy ; Houng, Aiilyan K. ; Liu, Lin ; Parhami-Seren, Behnaz ; Matsueda, Lee H. ; Wang, Shunguang ; Hedstrom, Lizbeth. / A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator. In: Proceedings of the National Academy of Sciences of the United States of America. 1999 ; Vol. 96, No. 16. pp. 8879-8883.
@article{ec36d6a75fdc481781a8acf6ccac0f2e,
title = "A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator",
abstract = "Plasminogen (Pg) activators such as streptokinase (SK) save lives by generating plasmin to dissolve blood clots. Some believe that the unique ability of SK to activate Pg in the absence of fibrin limits its therapeutic utility. We have found that SK contains an unusual NH2-terminal {"}catalytic switch{"} that allows Pg activation through both fibrin-independent and fibrin-dependent mechanisms. Unlike SK, a mutant (rSKΔ59) fusion protein lacking the 59 NH2-terminal residues was no longer capable of fibrin-independent Pg activation (kcat/Km decreased by >600-fold). This activity was restored by coincubation with equimolar amounts of the NH2-terminal peptide rSK1-59. Deletion of the NH2 terminus made rSKΔ59 a Pg activator that requires fibrin, but not fibrinogen, for efficient catalytic function. The fibrin-dependence of the rSKΔ59 activator complex apparently resulted from selective catalytic processing of fibrin-bound Pg substrates in preference to other Pg forms. Consistent with these observations, the presence (rSK) or absence (rSKΔ59) of the SK NH2-terminal peptide markedly altered fibrinolysis of human clots suspended in plasma. Like native SK, rSK produced incomplete clot lysis and complete destruction of plasma fibrinogen; in contrast, rSKΔ59 produced total clot lysis and minimal fibrinogen degradation. These studies indicate that structural elements in the NH2 terminus are responsible for SK's unique mechanism of fibrin-independent Pg activation. Because deletion of the NH2 terminus alters SK's mechanism of action and targets Pg activation to fibrin, there is the potential to improve SK's therapeutic efficacy.",
author = "Guy Reed and Houng, {Aiilyan K.} and Lin Liu and Behnaz Parhami-Seren and Matsueda, {Lee H.} and Shunguang Wang and Lizbeth Hedstrom",
year = "1999",
month = "8",
day = "3",
doi = "10.1073/pnas.96.16.8879",
language = "English (US)",
volume = "96",
pages = "8879--8883",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator

AU - Reed, Guy

AU - Houng, Aiilyan K.

AU - Liu, Lin

AU - Parhami-Seren, Behnaz

AU - Matsueda, Lee H.

AU - Wang, Shunguang

AU - Hedstrom, Lizbeth

PY - 1999/8/3

Y1 - 1999/8/3

N2 - Plasminogen (Pg) activators such as streptokinase (SK) save lives by generating plasmin to dissolve blood clots. Some believe that the unique ability of SK to activate Pg in the absence of fibrin limits its therapeutic utility. We have found that SK contains an unusual NH2-terminal "catalytic switch" that allows Pg activation through both fibrin-independent and fibrin-dependent mechanisms. Unlike SK, a mutant (rSKΔ59) fusion protein lacking the 59 NH2-terminal residues was no longer capable of fibrin-independent Pg activation (kcat/Km decreased by >600-fold). This activity was restored by coincubation with equimolar amounts of the NH2-terminal peptide rSK1-59. Deletion of the NH2 terminus made rSKΔ59 a Pg activator that requires fibrin, but not fibrinogen, for efficient catalytic function. The fibrin-dependence of the rSKΔ59 activator complex apparently resulted from selective catalytic processing of fibrin-bound Pg substrates in preference to other Pg forms. Consistent with these observations, the presence (rSK) or absence (rSKΔ59) of the SK NH2-terminal peptide markedly altered fibrinolysis of human clots suspended in plasma. Like native SK, rSK produced incomplete clot lysis and complete destruction of plasma fibrinogen; in contrast, rSKΔ59 produced total clot lysis and minimal fibrinogen degradation. These studies indicate that structural elements in the NH2 terminus are responsible for SK's unique mechanism of fibrin-independent Pg activation. Because deletion of the NH2 terminus alters SK's mechanism of action and targets Pg activation to fibrin, there is the potential to improve SK's therapeutic efficacy.

AB - Plasminogen (Pg) activators such as streptokinase (SK) save lives by generating plasmin to dissolve blood clots. Some believe that the unique ability of SK to activate Pg in the absence of fibrin limits its therapeutic utility. We have found that SK contains an unusual NH2-terminal "catalytic switch" that allows Pg activation through both fibrin-independent and fibrin-dependent mechanisms. Unlike SK, a mutant (rSKΔ59) fusion protein lacking the 59 NH2-terminal residues was no longer capable of fibrin-independent Pg activation (kcat/Km decreased by >600-fold). This activity was restored by coincubation with equimolar amounts of the NH2-terminal peptide rSK1-59. Deletion of the NH2 terminus made rSKΔ59 a Pg activator that requires fibrin, but not fibrinogen, for efficient catalytic function. The fibrin-dependence of the rSKΔ59 activator complex apparently resulted from selective catalytic processing of fibrin-bound Pg substrates in preference to other Pg forms. Consistent with these observations, the presence (rSK) or absence (rSKΔ59) of the SK NH2-terminal peptide markedly altered fibrinolysis of human clots suspended in plasma. Like native SK, rSK produced incomplete clot lysis and complete destruction of plasma fibrinogen; in contrast, rSKΔ59 produced total clot lysis and minimal fibrinogen degradation. These studies indicate that structural elements in the NH2 terminus are responsible for SK's unique mechanism of fibrin-independent Pg activation. Because deletion of the NH2 terminus alters SK's mechanism of action and targets Pg activation to fibrin, there is the potential to improve SK's therapeutic efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0033529762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033529762&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.16.8879

DO - 10.1073/pnas.96.16.8879

M3 - Article

VL - 96

SP - 8879

EP - 8883

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -